Influence of HLA-DRB1 allele heterogeneity on disease risk and clinical course in a West Australian MS cohort: A high-resolution genotyping study

Multiple Sclerosis

Volumn 16, Issue 5, 2010, Pages 526-532

  Wu, Jing Shan ^a,b,e   James, Ian ^c   Wei Qiu, ^a,b,f   Castley, Alison ^d   Christiansen, Frank T ^a,d   Carroll, William M ^a,b   Mastaglia, Frank L ^a,b   Kermode, Allan G ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

^d ROYAL PERTH HOSPITAL   (Australia)

^e SHANTOU UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY   (China)

Author keywords

High resolution genotype; Human leukocyte antigen (HLA); Multiple sclerosis; Susceptibility

Indexed keywords

HLA DR ANTIGEN;

ARTICLE; AUSTRALIA; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; IMMUNOGENETICS; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PROTECTION; SEX DIFFERENCE;

AGE OF ONSET; ALLELES; AUSTRALIA; DISEASE PROGRESSION; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; MALE; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 77952810083     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510362997     Document Type: Article

References (27)

1. Lincoln MR, Montpetit A., Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 2005 ; 37: 1108-1112.
2. Hafler DA, Compston A., Sawcer S., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med 2007 ; 357: 851-862.
3. Schmidt H., Williamson D., Ashley-Koch A. HLA-DR15 haplotype and multiple sclerosis: a HuGE review. Am J Epidemiol 2007 ; 165: 1097-1109.
4. Marrosu MG, Murru MR, Costa G., et al. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet 1998 ; 7: 1235-1237.
5. Masterman T., Ligers A., Olsson T., et al. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol 2000 ; 48: 211-219.
6. Caillier SJ, Briggs F., Cree BA, et al. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis. J Immunol 2008 ; 181: 5473-5480.
7. Stankovich J., Butzkueven H., Marriott M., et al. HLA-DRB1 associations with disease susceptibility and clinical course in Australians with multiple sclerosis. Tissue Antigens 2009 ; 74: 17-21.
8. Fernandez O., R-Antigüedad A., Pinto-Medel MJ, et al. HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain). J Neurol 2009 ; [Epub ahead of print].
9. Ballerini C., Guerini FR, Rombola G., et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol 2004 ; 150: 178-185.
10. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: susceptibility and resistance. Hum Mol Genet 2005 ; 14: 2019-2026.
11. Barcellos LF, Sawcer S., Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 2006 ; 15: 2813-2824.
12. Lincoln MR, Ramagopalan SV, Chao MJ, et al. Epistasis among HLA-DRB1, HLA-DQA1, and HLA-DQB1 loci determines multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2009 ; 106: 7542-7547.
13. Chao MJ, Barnardo MC, Lincoln MR, et al. HLA class I alleles tag HLA-DRB1*1501 haplotypes for differential risk in multiple sclerosis susceptibility. Proc Natl Acad Sci U S A 2008 ; 105: 13069-13074.
14. Ramagopalan SV, Ebers GC Epistasis: multiple sclerosis and the major histocompatibility complex. Neurology 2009 ; 72: 566-567.
15. Kwon OJ, Karni A., Israel S., et al. HLA class II susceptibility to multiple sclerosis among Ashkenazi and non-Ashkenazi Jews. Arch Neurol 1999 ; 56: 555-560.
16. Marrosu MG, Murru R., Murru MR, et al. Dissection of the HLA association with multiple sclerosis in the founder isolated population of Sardinia. Hum Mol Genet 2001 ; 10: 2907-2916.
17. Listgarten J., Brumme Z., Kadie C., et al. Statistical resolution of ambiguous HLA typing data. PLoS Comput Biol 2008 ; 4: e1000016.
18. Svejgaard A. The immunogenetics of multiple sclerosis. Immunogenetics 2008 ; 60: 275-286.
19. Wu JS, Zhang MN, Carroll WM, et al. Characterisation of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry 2008 ; 79: 1022-1026.
20. Poser CM, Paty DW, Scheinberg L., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals of Neurology 1983 ; 13: 227-231.
21. Compston A., Edan G., Goodkin D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals of Neurology 2001 ; 50: 121-127.
22. Welborn TA The Busselton Study: mapping population health. Cardiovascular and respiratory disease risk factors in Busselton, Australia. Sydney: Australasian Medical Publishing Company, 1998.
23. Sayer D., Whidborne R., Brestovac B., et al. HLA-DRB1 DNA sequencing based typing: an approach suitable for high throughput typing including unrelated bone marrow registry donors. Tissue Antigens 2001 ; 57: 46-54.
24. Roxburgh RH, Seaman SR, Masterman T., et al. Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity. Neurology 2005 ; 64: 1144-1151.
25. Ramagopalan SV, Herrera BM, Bell JT, et al. Parental transmission of HLA-DRB1*15 in multiple sclerosis. Hum Genet 2008 ; 122: 661-663.
26. Hensiek AE, Sawcer SJ, Feakes R., et al. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry 2002 ; 72: 184-187.
27. Wu JS, Qiu W., Castley A., et al. Modifying effects of HLA-DRB1 allele interactions on age at onset of multiple sclerosis in Western Australia. Mult Scler 2009 ; 16: 15-20.